Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in EnglandYen Yi Tan, Alvina G. Lai, Václav Papež et al.|The Lancet Healthy Longevity|2022Cited by 280
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort studyErica A. Voss, Rohit Vashisht, Kevin Haynes et al.|EClinicalMedicine|2023Cited by 27
Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort StudyAzza Shoaibi, Patrick Ryan, Gowtham Rao et al.|Drug Safety|2022Cited by 10